The global topical drugs CDMO market size is calculated at USD 51.79 billion in 2025 and is forecasted to reach around USD 136.39 billion by 2034, accelerating at a CAGR of 11.33% from 2025 to 2034. The Asia Pacific topical drugs CDMO market size surpassed USD 17.09 billion in 2025 and is expanding at a CAGR of 11.50% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Topical Drugs CDMO Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Topical Drugs CDMO Market Revenue and Volume, by Product Type
8.1.1 Semi-solid Formulations
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Liquid Formulations Drugs
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Solid Formulations
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Transdermal Products
8.1.4.1. Market Revenue and Volume Forecast
9.1. Topical Drugs CDMO Market Revenue and Volume, by Service
9.1.1. Contract Development
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Contract Manufacturing
9.1.2.1. Market Revenue and Volume Forecast
10.1. Topical Drugs CDMO Market Revenue and Volume, by End-use
10.1.1. Pharmaceutical Companies
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Biopharmaceutical Companies
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Others
10.1.3.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product Type
11.1.2. Market Revenue and Volume Forecast, by Service
11.1.3. Market Revenue and Volume Forecast, by End-use
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product Type
11.1.4.2. Market Revenue and Volume Forecast, by Service
11.1.4.3. Market Revenue and Volume Forecast, by End-use
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product Type
11.1.5.2. Market Revenue and Volume Forecast, by Service
11.1.5.3. Market Revenue and Volume Forecast, by End-use
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product Type
11.2.2. Market Revenue and Volume Forecast, by Service
11.2.3. Market Revenue and Volume Forecast, by End-use
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product Type
11.2.4.2. Market Revenue and Volume Forecast, by Service
11.2.4.3. Market Revenue and Volume Forecast, by End-use
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product Type
11.2.5.2. Market Revenue and Volume Forecast, by Service
11.2.5.3. Market Revenue and Volume Forecast, by End-use
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product Type
11.2.6.2. Market Revenue and Volume Forecast, by Service
11.2.6.3. Market Revenue and Volume Forecast, by End-use
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product Type
11.2.7.2. Market Revenue and Volume Forecast, by Service
11.2.7.3. Market Revenue and Volume Forecast, by End-use
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product Type
11.3.2. Market Revenue and Volume Forecast, by Service
11.3.3. Market Revenue and Volume Forecast, by End-use
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product Type
11.3.4.2. Market Revenue and Volume Forecast, by Service
11.3.4.3. Market Revenue and Volume Forecast, by End-use
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product Type
11.3.5.2. Market Revenue and Volume Forecast, by Service
11.3.5.3. Market Revenue and Volume Forecast, by End-use
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product Type
11.3.6.2. Market Revenue and Volume Forecast, by Service
11.3.6.3. Market Revenue and Volume Forecast, by End-use
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product Type
11.3.7.2. Market Revenue and Volume Forecast, by Service
11.3.7.3. Market Revenue and Volume Forecast, by End-use
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product Type
11.4.2. Market Revenue and Volume Forecast, by Service
11.4.3. Market Revenue and Volume Forecast, by End-use
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product Type
11.4.4.2. Market Revenue and Volume Forecast, by Service
11.4.4.3. Market Revenue and Volume Forecast, by End-use
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product Type
11.4.5.2. Market Revenue and Volume Forecast, by Service
11.4.5.3. Market Revenue and Volume Forecast, by End-use
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product Type
11.4.6.2. Market Revenue and Volume Forecast, by Service
11.4.6.3. Market Revenue and Volume Forecast, by End-use
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product Type
11.4.7.2. Market Revenue and Volume Forecast, by Service
11.4.7.3. Market Revenue and Volume Forecast, by End-use
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product Type
11.5.2. Market Revenue and Volume Forecast, by Service
11.5.3. Market Revenue and Volume Forecast, by End-use
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product Type
11.5.4.2. Market Revenue and Volume Forecast, by Service
11.5.4.3. Market Revenue and Volume Forecast, by End-use
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product Type
11.5.5.2. Market Revenue and Volume Forecast, by Service
11.5.5.3. Market Revenue and Volume Forecast, by End-use
12.1. Lubrizol Life Science (U.S.)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Cambrex Corporation (U.S.)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Contract Pharmaceuticals Limited (Canada)
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Bora Pharmaceutical CDMO (Taiwan)
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Ascendia Pharmaceuticals (U.S.)
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Pierre Fabre group (France)
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Piramal Pharma Solutions (India)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. DPT Laboratories LTD. (U.S.)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. MedPharm Ltd. (U.S.)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. PCI Pharma Services (U.S.)
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample